1112233-63-2 Usage
Uses
Used in Pharmaceutical Research:
(S)-ethyl 2-(((S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl)amino)-4-fluoro-4-methylpentanoate is used as a compound in pharmaceutical research for its potential to interact with various biological targets and contribute to the development of new drugs.
Used in Chemical Research:
In chemical research, (S)-ethyl 2-(((S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl)amino)-4-fluoro-4-methylpentanoate is used as a starting material or intermediate in the synthesis of more complex molecules, potentially leading to novel chemical entities with specific applications.
Used in Medicinal Chemistry:
(S)-ethyl 2-(((S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl)amino)-4-fluoro-4-methylpentanoate is used as a building block in medicinal chemistry, where its unique structure may be exploited to design and develop new therapeutic agents with improved pharmacological properties.
Used in Drug Delivery Systems:
(S)-ethyl 2-(((S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl)amino)-4-fluoro-4-methylpentanoate may be employed in the development of drug delivery systems, where its structural features could be utilized to enhance the solubility, stability, or targeted delivery of therapeutic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1112233-63-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,2,2,3 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1112233-63:
(9*1)+(8*1)+(7*1)+(6*2)+(5*2)+(4*3)+(3*3)+(2*6)+(1*3)=82
82 % 10 = 2
So 1112233-63-2 is a valid CAS Registry Number.
1112233-63-2Relevant academic research and scientific papers
A practical enantioselective synthesis of odanacatib, a potent cathepsin K inhibitor, via triflate displacement of an α-Trifluoromethylbenzyl triflate
O'Shea, Paul D.,Chen, G-Yi,Gauvreau, Danny,Gosselin, Francis,Hughes, Greg,Nadeau, Christian,Volante, Ralph P.
experimental part, p. 1605 - 1610 (2009/08/19)
An enantioselective synthesis of the Cathepsin K inhibitor odanacatib (MK-0822) 1 is described. The key step involves the novel stereospecific S N2 triflate displacement of a chiral α-trifluoromethylbenzyl triflate 9a with (S)-γ-fluoroleucine e
